The study is aimed at assessing the influence of two betaine doses (2.5 g∙d-1 and 5 g∙d-1) supplemented for three weeks in a group of speed-strength trained athletes on anaerobic capacity in Wingate test, performance in CrossFit-like exercise test - Fight Gone Bad, alterations in body compositions and total body water.
The main aim of the project is the assessment of the effects of 3 weeks supplementation with two doses of betaine (2.5 g∙d-1 and 5 g∙d-1) on anaerobic capacity, CrossFit performance, body composition, and betaine metabolism in a group of male speed-strength trained athletes. The study is designed as a double-blind, randomized, placebo-controlled crossover trial. 80 male participants will be divided randomly into two parallel groups: one receiving 2.5 g·d-1 betaine and the second receiving 5 g·d-1 betaine. In both experimental groups participants will receive both betaine supplement or placebo in a random order. The supplementation periods (betaine and placebo) will last for three weeks each and will be separated by a 3-week washout. The participants will attend four study meetings at the Institute of Human Nutrition and Dietetics, Poznan University of Life Sciences, Poland. Food intake before and during the intervention will be assessed with the use of food diary and intakes of macro- and micronutrients will be calculated with the use of Dieta 5.0 software. On each visit Wingate ergocycling test will be performed, body composition will be measured and blood samples will be taken. The same day in the afternoon/evening hours the Fight Gone Bad (FGB) test will be performed. Body composition will be assessed based on air displacement plethysmography technology using the Bod Pod®. Moreover, total body water content will be analyzed by bioelectric impedance with the use of a BIA 101S analyzer. Anaerobic capacity will be assessed using the classical Wingate test on a cycloergometer. In order to assess CrossFit performance the FGB test will be performed. In blood samples the investigators plan to analyze concentrations of: lipoproteins and triglycerides (biochemical analyzer), betaine (LC-MS method), amino acid profile (LC-MS method), and testosterone (ELISA). MTHFR genotype will be analyzed with using a PCR-RFLP method. Data will be analyzed using the STATISTICA 12 software program.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
80
Group taking oral betaine supplementation
Group taking oral supplementation with placebo (starch) in a similar capsule form.
Institute of Human Nutrition and Dietetics, Poznan University of Life Sciences
Poznan, Poland
RECRUITINGChanges in fat mass and fat free mass after betaine supplementation
Fat mass (kg) and fat free mass (kg) analysis
Time frame: Baseline and after 3 weeks
Changes in anaerobic capacity after betaine supplementation
The Wingate cycling test (W)
Time frame: Baseline and after 3 weeks
Changes in specific performance capacity after betaine supplementation
The CrossFit-specific physical fitness test: Fight Gone Bad (reps.)
Time frame: Baseline and after 3 weeks
Changes in total body water after betaine supplementation
Total body water content (%)
Time frame: Baseline and after 3 weeks
Changes in testosterone level (ng/L) after betaine supplementation
Testosterone level (ng/L)
Time frame: Baseline and after 3 weeks
Changes in amino acid profile after betaine supplementation
Amino acid profile (μmol/L)
Time frame: Baseline and after 3 weeks
Changes in blood betaine
Blood betaine (µmol/L)
Time frame: Baseline and after 3 weeks
Changes in total, LDL and HDL cholesterol and triacylglycerol after betaine supplementation
Total, LDL and HDL cholesterol (mg/dL) and triacylglycerol (mg/dL)
Time frame: Baseline and after 3 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Difference in response to betaine supplementation depending on MTHFR (rs1801133) polymorphism
MTHFR (rs1801133) polymorphism
Time frame: Baseline and after 3 weeks